National Cancer Institute Amended; Notice of Meeting, 7874 [2015-02960]
Download as PDF
<![CDATA[
7874
Federal Register / Vol. 80, No. 29 / Thursday, February 12, 2015 / Notices
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Tech
Tools to Facilitate Implementation (5581).
Date: March 17, 2015.
Time: 11:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Lyle Furr, Scientific
Review Officer, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 4227, MSC 9550, 6001
Executive Boulevard, Bethesda, MD 20892–
9550, (301) 435–1439, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: February 6, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–02879 Filed 2–11–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Rmajette on DSK2VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Fatty Liver
Ancillary Studies.
Date: March 9, 2015.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Robert Wellner, Ph.D.,
Scientific Review Officer, Review Branch,
Dea, Niddk, National Institutes of Health,
Room 706, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, 301–594–4721,
rw175w@nih.gov.
VerDate Sep<11>2014
17:37 Feb 11, 2015
Jkt 235001
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Genomic Diagnosis
for Chronic Kidney Disease.
Date: March 17, 2015.
Time: 3:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Robert Wellner, Ph.D.,
Scientific Review Officer, Review Branch,
Dea, Niddk, National Institutes Of Health,
Room 706, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, 301–594–4721,
rw175w@nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Reagents for
Glucagon and Incretin Research (R43/R44).
Date: March 19, 2015.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Jian Yang, Ph.D., Scientific
Review Officer, Review Branch, Dea, Niddk,
National Institutes of Health, Room 755, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301) 594–7799, yangj@
extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: February 9, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–02958 Filed 2–11–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute Amended;
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Clinical Trials and
Translational Research Advisory
Committee, March 04, 2015, 09:00 a.m.
to March 04, 2015, 04:00 p.m., National
Institutes of Health, Building 31, CWing, 6th Floor, 31 Center Drive, Room
10, Bethesda, MD 20892 which was
published in the Federal Register on
January 09, 2015, 801428.
The meeting notice is amended to
reflect that the meeting will also be
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
available via https://videocast.nih.gov
The meeting is open to the public.
Dated: February 9, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–02960 Filed 2–11–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Review of Proposals for Inhibiting
Transcription Factors in Hematologic
Malignancies Therapy.
Date: March 6, 2015.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6701
Rockledge Drive, Room 7196, Bethesda, MD
20892 (Telephone Conference Call).
Contact Person: Stephanie J Webb, Ph.D.
Scientific Review Officer, Office of Scientific
Review/DERA National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7196, Bethesda, MD 20892, 301–435–0291
stephanie.webb@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS).
Dated: February 6, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–02880 Filed 2–11–15; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\12FEN1.SGM
12FEN1
]]>Agencies
[Federal Register Volume 80, Number 29 (Thursday, February 12, 2015)]
[Notices]
[Page 7874]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-02960]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute Amended; Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Cancer Institute Clinical Trials and Translational Research Advisory
Committee, March 04, 2015, 09:00 a.m. to March 04, 2015, 04:00 p.m.,
National Institutes of Health, Building 31, C-Wing, 6th Floor, 31
Center Drive, Room 10, Bethesda, MD 20892 which was published in the
Federal Register on January 09, 2015, 801428.
The meeting notice is amended to reflect that the meeting will also
be available via https://videocast.nih.gov The meeting is open to the
public.
Dated: February 9, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-02960 Filed 2-11-15; 8:45 am]
BILLING CODE 4140-01-P
